Stephanie Howe Guarino, MD
Hematology/OncologyInsurance Accepted
- Aetna Better Health PA Kids HMO
- Aetna HMO
- Aetna PPO/POS/EPO
- Amerihealth Caritas DE - PENNSYLVANIA SPECIALISTS ONLY
- Amerihealth Caritas Delaware
- Amerihealth Caritas Delaware Next
- Carefirst MD Community Health Plan Mcaid
- Cigna/Great West HMO EPO POS
- Cigna/Great West PPO
- Delaware First Health
- Delaware Medicaid/Diamond State
- Delaware Medicare
- Devon Health Services
- Fidelis Care NJ Medicaid HMO
- First Health/Affordable PPO
- Geisinger Health Plan Commercial
- Global Medical Managment DE/PA
- Health Partners Medicaid/Kidz Partner HMO
- Highmark Blue Cross Blue Shield of Delaware
- Highmark Blue Cross Blue Shield of Pennsylvania
- Highmark Medicaid Health Options
- Horizon Blue Cross Blue Shield of New Jersey
- Independance Blue Cross/Amerihealth/Keystone Health Plan
- Insurance Administrators of America
- INTEGRA Administrative Group (ClaimsBridge)
- Keystone First Medicaid HMO
- Lifetrac Transplant
- Maryland Medicaid
- Multiplan PPO
- National Transplant (Humana)
- New Jersey Medicaid
- Olympus Managed Healthcare PPO DE/PA
- Pennsylvania Medicaid
- Plan Vista/NPPN PPO
- Preferred Healthcare PPO
- Private Health Care Systems (PHCS)
- Qualcare HMO/POS/PPO
- Star Healthcare Network
- Three Rivers Provider Network
- Tricare/Humana Military Health Services/CHAMPVA
- United Healthcare of the Mid-Atlantic
- UPMC MCAID/CHIP PA DE
- US Family Health Plan
- Wellpoint Maryland Medcaid
- Bone Tumors
- Cancer Care
- Leukemia
- Lymphoma
- Solid Tumors
-
AML in Distinct Age-Defined Populations of Infants, Adolescents and Young Adults; Pediatric Oncology; (2024).
View Full Publication -
Expert consensus on the management of infusion-related reactions (IRRs) in patients with sickle cell disease (SCD) receiving crizanlizumab: a RAND/UCLA modified Delphi panel; Annals of Hematology; (2024).
View Full Publication -
COVID-19 in hospitalized adult patients with sickle cell disease: A 2020 US cohort using Cerner Real-World Data<sup>™</sup>(CRWD); Journal of Clinical and Translational Science; (2023).
View Full Publication -
Peer Mediated Groups: Nonpharmacologic Management of Pain for and By Those with Sickle Cell Disease; Delaware Journal of Public Health; (2022).
View Full Publication -
How to utilize new therapies for sickle cell disease; Hematology (United States); (2022).
View Full Publication -
Reflections from physician scientists on the front lines of covid-19; Delaware Journal of Public Health; (2020).
View Full Publication
- English